nexium mixtúrukyrni, dreifa 10 mg
grünenthal gmbh* - esomeprazolum magnesíum - mixtúrukyrni, dreifa - 10 mg
nexium stungulyfs-/innrennslisstofn, lausn 40 mg
grünenthal gmbh* - esomeprazolum natríum - stungulyfs-/innrennslisstofn, lausn - 40 mg
pentasa endaþarmsstíll 1 g
ferring lægemidler a/s - mesalazinum inn - endaþarmsstíll - 1 g
clindamycin eql pharma hart hylki 150 mg
eql pharma ab - clindamycinum hýdróklóríð - hart hylki - 150 mg
azitromicina normon filmuhúðuð tafla 500 mg
laboratorios normon s.a. - azithromycinum díhýdrat - filmuhúðuð tafla - 500 mg
betnovat húðlausn 1 mg/ml
glaxosmithkline pharma a/s - betamethasonum valerat - húðlausn - 1 mg/ml
clindamycin eql pharma hart hylki 300 mg
eql pharma ab - clindamycinum hýdróklóríð - hart hylki - 300 mg
dexdor
orion corporation - dexmedetomidine hydrochloride - meðvitandi sedation - psycholeptics - til róandi fullorðinsþjálfunaraðila sem krefjast róandi stigs ekki dýpra en vökva sem svar við munnlegri örvun (samsvarandi richmond agitation-sedation scale (rass) 0 til -3).
tygacil
pfizer europe ma eeig - tigecycline - bacterial infections; skin diseases, bacterial; soft tissue infections - sýklalyf fyrir almenn nota, - tygacil is indicated in adults and in children from the age of eight years for the treatment of the following infections: , complicated skin and soft tissue infections (cssti), excluding diabetic foot infections, complicated intra-abdominal infections (ciai) , tygacil should be used only in situations where other alternative antibiotics are not suitable. Íhuga ætti að opinbera leiðsögn á réttri notkun af sýklalyfjum. viðeigandi að nota af sýklalyfjum.
zavicefta
pfizer ireland pharmaceuticals - avibactam sodium, ceftazidime pentahydrate - pneumonia, bacterial; soft tissue infections; pneumonia; urinary tract infections; gram-negative bacterial infections - sýklalyf fyrir almenn nota, - zavicefta is indicated in adults and paediatric patients aged 3 months and older for the treatment of the following infections:complicated intra-abdominal infection (ciai)complicated urinary tract infection (cuti), including pyelonephritishospital-acquired pneumonia (hap), including ventilator associated pneumonia (vap)treatment of patients with bacteraemia that occurs in association with, or is suspected to be associated with, any of the infections listed above. zavicefta is also indicated for the treatment of infections due to aerobic gram-negative organisms in adults and paediatric patients aged 3 months and older with limited treatment options. Íhuga ætti að opinbera leiðsögn á réttri notkun af sýklalyfjum.